VA Medical Center and UC College of Medicine Create General Clinical Research Center
The Department of Veterans Affairs (VA) Medical Center, Cincinnati, and the University of Cincinnati (UC) College of Medicine have established a site to study adults with complex medical or psychiatric disorders. The new site, named the General Clinical Research Center (GCRC), will accommodate studies from a variety of sponsors including the National Institutes of Health (NIH) and the VA Research Programs. A ribbon cutting ceremony will be held on April 15 at 1:00 p.m. in the GCRC located on the 4th floor of the Cincinnati VA. This ceremony is open to the public.
The GCRC offers a wide range of support to researchers including assistance with grant preparation and submission, Institutional Review Board and VA Research and Development Committee submission and processing, grant budgets and contracts, study assessments, and study logistics.
The GCRC space is made up of two monitored rooms for inpatients, five outpatient examination rooms, an investigational pharmacy, a phlebotomy room, and a fully equipped cardiac physiology laboratory.
Stephen M. Strakowski, MD, professor in the UC Department of Psychiatry, was appointed by the Cincinnati VA as the director of the GCRC. VA Associate Directors of the GCRC are Dave D'Alessio, MD, associate professor in the UC Department of Internal Medicine/Division of Endocrinology; and Paul E. Keck, MD, professor in the UC Department of Psychiatry.
For more information contact the GCRC Administrator Amelia T. Nasrallah by phone at (513) 558-2226 or (513) 861-3100, ext. 4486, or e-mail
.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.